Home Health Gains in cancer treatment through the eyes of a survivor

Gains in cancer treatment through the eyes of a survivor

0
42
The panel, l to r: Tom Lynch, Chief Scientific Officer, Bristol-Myers Squibb; Arlene Sharpe, George Fabyan Professor of Comparative Pathology, Harvard Medical School; Linnea Olson, former lung cancer patient and activist; Alice Shaw, Associate Professor of Medicine, Harvard Medical School; and moderator Stanley Shaw, Associate Dean for Executive Education, Harvard Medical School. An interactive conversation on the scientific, business and human stories behind the recent successes and the emerging biotech/pharmacology pipeline. .Jon Chase/Harvard Staff Photographer.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

.td-header-style-1 .td-header-sp-logo {width:400px;}